Advanced Enzyme Technologies Limited — PPTs, 31-01-2026: Investor Presentation

Advanced Enzyme Technologies reported Q3 FY26 revenue up 2% YoY to ₹171.9 Cr, though EBITDA dipped 11% to ₹49.4 Cr. Despite this, Net Profit jumped 11% to ₹43.2 Cr, potentially aided by an exceptional gain. For the nine months, revenue grew 15% to ₹542.4 Cr, EBITDA rose 11% to ₹165.8 Cr, and PAT surged 20% to ₹128.4 Cr. Human Nutrition saw a 6% decline in Q3, while Animal Nutrition and Industrial Bio-Processing grew 22% and 13% respectively. India sales rose 6%, but Americas and Europe saw slight dips.

The company plans to fuel growth through continued R&D investment for new enzymes and probiotics, broadening its global presence via strategic partnerships, and inorganic expansion. Recent developments include the launch of its B2C consumer brand Wellfa and commissioning a 510kW solar power plant.

EPS for Q3 FY26 was ₹3.80, up 13% YoY, and for 9M FY26, it was ₹11.24, up 20% YoY.

Management is focused on expanding its Animal Nutrition product line and sales team, launching new Probiotics for human and animal health, developing bio-catalysis solutions for API manufacturers, and expanding its Baking solutions globally.